NSE
Aarti Drugs LimitedAARTIDRUGS
Aarti Drugs Limited is an Indian pharmaceutical company focused on manufacturing and marketing of generic drugs.
| Key products | Generic drugs, APIs (Active Pharmaceutical Ingredients) |
|---|---|
| Geography | India, Export markets in Southeast Asia, Middle East |
| Competitors | Dr Reddy's Laboratories, Cipla |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Interim Dividend - Rs 2 Per Share
ex 2026-02-09
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | AARTIDRUGSThis | +₹0 Cr | 2 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • [object Object]
- • [object Object]
Weaknesses
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
Timeline — AARTIDRUGS day by day
- 2026-02-09ActionInterim Dividend - Rs 2 Per ShareDividend
- 2025-05-07BulkBUY · ₹31.6 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-05-07BulkSELL · ₹31.6 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-02-04ActionInterim Dividend - Re 1 Per ShareDividend
- 2024-09-05ActionBuy BackBuyback
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
No scored filings for AARTIDRUGS yet.
2 deals · 2025-05-07 → 2025-05-07
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-05-07 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹31.6 Cr |
| 2025-05-07 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹31.6 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on AARTIDRUGS
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.